InNexus Biotechnology, Inc.
IXSBF · OTC
6/30/2010 | 6/30/2009 | 6/30/2008 | 6/30/2007 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $1 | $15 |
| % Growth | – | -100% | -93.4% | – |
| Cost of Goods Sold | $468 | $453 | $610 | $242 |
| Gross Profit | $0 | $0 | -$610 | -$242 |
| % Margin | – | – | -60,403.4% | -1,583.8% |
| R&D Expenses | $1,156 | $2,305 | $3,813 | $2,129 |
| G&A Expenses | $2,280 | $4,397 | $0 | $0 |
| SG&A Expenses | $2,280 | $4,397 | $4,610 | $3,658 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $494 | -$2,777 | -$2,710 | -$639 |
| Operating Expenses | $3,930 | $6,702 | $5,713 | $5,148 |
| Operating Income | -$3,930 | -$6,702 | -$5,712 | -$5,133 |
| % Margin | – | – | -565,567.3% | -33,603.6% |
| Other Income/Exp. Net | $3,930 | -$1,095 | -$351 | -$121 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6,689 | -$8,017 | -$5,888 | -$5,172 |
| % Margin | – | – | -582,934.9% | -33,861.5% |
| EPS | -0.07 | -0.11 | -0.11 | -0.13 |
| % Growth | 36.4% | 0% | 15.4% | – |
| EPS Diluted | -0.07 | -0.11 | -0.11 | -0.13 |
| Weighted Avg Shares Out | 96,337 | 75,287 | 55,259 | 43,943 |
| Weighted Avg Shares Out Dil | 96,337 | 75,287 | 55,259 | 43,943 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $3 | $77 | $159 |
| Interest Expense | $2,794 | $1,314 | $253 | $199 |
| Depreciation & Amortization | $988 | $410 | $502 | $242 |
| EBITDA | -$2,942 | -$6,293 | -$5,210 | -$5,497 |
| % Margin | – | – | -515,888.8% | -35,991.8% |